Integrated genomic analyses in bronchopulmonary dysplasia

Area of Science:

• Genetics
• Neonatal Medicine
• Pulmonary Biology

Background:

• Bronchopulmonary dysplasia (BPD) is a significant complication in extremely low birth weight infants.
• Genetic factors are known to influence the risk and severity of BPD.
• Understanding the genetic basis of BPD is crucial for developing targeted interventions.

Purpose of the Study:

• To identify single-nucleotide polymorphisms (SNPs) and genetic pathways associated with BPD.
• To investigate the genetic predisposition to BPD in extremely low birth weight infants.

Main Methods:

• Genome-wide association study (GWAS) on 1.2 million genotyped and 7 million imputed SNPs.
• Gene set enrichment analysis for BPD and its severity outcomes.
• Validation of key genetic targets using gene expression in BPD lung tissue and mouse models.

Main Results:

• No SNPs reached genome-wide significance, but several were near significance (e.g., adenosine deaminase, CD44).
• Pathway analysis revealed significant associations for 75-95 pathways, including miR-219 targets and phosphorous oxygen lyase activity.
• Gene expression confirmed elevated miR-219 and CD44 levels in BPD lung tissue.

Conclusions:

• Pathway analysis highlights the role of known lung development pathways (CD44, phosphorous oxygen lyase activity) in BPD.
• Novel molecular targets, including adenosine deaminase and miR-219 targets, are implicated in the genetic predisposition to BPD.
• These findings contribute to understanding the genetic architecture of BPD.